PRANAYAMA BASED MOBILE APP FOR BREAST CANCER SURVIVORSHIP: I-CORPS SUPPLEMENT

基于调息的乳腺癌幸存者移动应用程序:I-CORPS 补充品

基本信息

项目摘要

PROJECT SUMMARY Cancer remains the second leading cause of deaths in the U.S. Encouragingly, recent improvements in early diagnosis and treatment has led to significant increases in the survival rate of cancer patients. As cancer becomes a chronic but manageable disease for thousands of survivors, the long-term physical and psychological side effects of treatment protocols is becoming more apparent, as is the impact of these issues on disease-free or overall survival. As a result of this changing landscape, survivorship care programs and approaches that incorporate non-pharmacological lifestyle and mind-body interventions are becoming increasingly critical components of the patient treatment pathway. In this regard, integrative approaches such as yogic breathing (YB), a collection of techniques to voluntarily regulate breathing, have emerged as an effective complementary therapy for cancer patients. YB is well-established to induce strong relaxation responses via vagal and parasympathetic stimulation. YB is easy to practice using virtual tools such as mobile apps especially during the current scenario of COVID-19 pandemic and social distancing. In this application, PranaScience seeks to develop a novel group video app for YB that is optimized for home-based delivery of a proscribed YB program that is maximally effective in promoting peer support, and relieving symptomatic conditions associated with cancer treatment and survivorship. This intervention is based on compelling preliminary data generated by the PI of this proposal demonstrating that specific YB exercises induce alterations in the levels of proteins associated with tumor suppression, immune regulation, neuromodulation, and stress response/ inflammation, as well as pilot studies performed in cancer survivors and other patient/general populations indicating that participants are interested in a YB intervention and perceive improvements in well-being after YB sessions. In this Phase I STTR, PranaScience (1) has built a first production version of a culturally neutral group video YB app and (2) partners with the Medical University of South Carolina (MUSC) to pilot test the YB app in breast cancer survivors to evaluate adherence, feasibility, and acceptability of the app to support symptom management. App usage data is collected and used to evaluate adherence to the program, and acceptability for symptom management will be evaluated using a series of defined biobehavioral measures at baseline and following a 12-week implementation period. Exploratory salivary and fingernail biomarker analysis focused on tumor suppressors, inflammatory cytokines, proteome level alterations, and stress hormones will be performed at baseline and at week 12. Structured, focus group interviews of study participants will be used to assess technology perception/ program feasibility and will inform future design optimizations. Information from the I-Corps supplemental work will be used to refine app in preparation for large-scale evaluation in Phase II, and for commercialization purposes through customer discovery interviews.
项目摘要 癌症仍然是美国死亡的第二大原因,令人鼓舞,最近的早期改善 诊断和治疗导致癌症患者的存活率显着提高。作为癌症 对于成千上万的幸存者来说,成为一种慢性但易于管理的疾病,这是长期的身体和心理 治疗方案的副作用变得越来越明显,这些问题对无疾病的影响也越来越明显 或总体生存。由于这种不断变化的景观,生存护理计划和方法 融合非药物的生活方式和心身干预措施正在变得越来越关键 患者治疗途径的成分。在这方面,诸如瑜伽呼吸之类的综合方法 (YB)是自愿调节呼吸的技术的集合,已成为有效的补充 癌症患者的治疗。 YB的建立良好,可以通过迷走神经和 副交感神经刺激。 YB很容易使用虚拟工具(例如移动应用程序)进行练习 Covid-19-19的当前情况大流行和社会疏远。在此应用中,Pranasciencies试图 为YB开发一个新颖的小组视频应用程序,该应用程序针对禁止的YB计划的基于家庭的交付进行了优化 这对于促进同伴支持和缓解与症状条件相关的最大有效 癌症治疗和生存。此干预措施基于由 该提案的PI表明特定的YB行使会导致相关蛋白质水平的改变 肿瘤抑制,免疫调节,神经调节和应激反应/炎症以及 在癌症幸存者和其他患者/一般人群中进行的试验研究表明参与者是 YB会议后的YB干预和感知的健康感兴趣。在这个阶段我sttr, Pranasciencienciencienciencie(1)已建立了文化中立的团体视频YB应用程序和(2)合作伙伴的首个生产版本 与南卡罗来纳州医科大学(MUSC)一起测试乳腺癌幸存者的YB应用程序 评估该应用程序支持症状管理的依从性,可行性和可接受性。应用使用数据 收集并用于评估遵守该计划的依从性,症状管理的可接受性将是 在基线时使用一系列定义的生物行为措施进行评估,并在实施12周之后进行评估 时期。探索性唾液和指甲生物标志物分析以肿瘤抑制剂为重点 细胞因子,蛋白质组水平的改变和应力激素将在基线和第12周进行。 结构化的研究参与者的焦点小组访谈将用于评估技术知觉/计划 可行性,并将为未来的设计优化提供信息。 I-Corps补充工作的信息将是 用于在第二阶段进行大规模评估的准备应用程序,并用于商业化目的 通过客户发现访谈。

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
A quality improvement study on the feasibility and potential benefits of a yogic breathing program for cancer survivors and caregivers during treatment in a lodging facility.
一项关于癌症幸存者和护理人员在住宿设施治疗期间进行瑜伽呼吸计划的可行性和潜在益处的质量改进研究。
  • DOI:
    10.1016/j.bbii.2023.100019
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Alford,ChristinaM;Wahlquist,AmyE;Sterba,KatherineR;Warren,GrahamW;Balasubramanian,Sundaravadivel
  • 通讯作者:
    Balasubramanian,Sundaravadivel
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUNDARAVADIVEL BALASUBRAMANIAN其他文献

SUNDARAVADIVEL BALASUBRAMANIAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUNDARAVADIVEL BALASUBRAMANIAN', 18)}}的其他基金

PRANAYAMA BASED GROUP VIDEO APP FOR CANCER SURVIVORSHIP. Phase I. Breast Cancer Pilot
基于调息的癌症幸存者团体视频应用程序。
  • 批准号:
    10156943
  • 财政年份:
    2021
  • 资助金额:
    $ 5.5万
  • 项目类别:

相似海外基金

PRANAYAMA BASED GROUP VIDEO APP FOR CANCER SURVIVORSHIP. Phase I. Breast Cancer Pilot
基于调息的癌症幸存者团体视频应用程序。
  • 批准号:
    10156943
  • 财政年份:
    2021
  • 资助金额:
    $ 5.5万
  • 项目类别:
Administrative Core
行政核心
  • 批准号:
    10252803
  • 财政年份:
    2018
  • 资助金额:
    $ 5.5万
  • 项目类别:
Impact of COVID-19 on cancer care delivery among diverse populations
COVID-19 对不同人群癌症护理服务的影响
  • 批准号:
    10203686
  • 财政年份:
    2018
  • 资助金额:
    $ 5.5万
  • 项目类别:
AIDS Malignancy Clinical Trials Consortium
艾滋病恶性肿瘤临床试验联盟
  • 批准号:
    7689546
  • 财政年份:
    2006
  • 资助金额:
    $ 5.5万
  • 项目类别:
AIDS Malignancy Clinical Trials Consortium
艾滋病恶性肿瘤临床试验联盟
  • 批准号:
    7689549
  • 财政年份:
    2006
  • 资助金额:
    $ 5.5万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了